Figure 2 Cell-mediated disease mechanisms of lupus nephritis

Slides:



Advertisements
Similar presentations
Functions Receptors Signaling Chapter 11
Advertisements

Proposed pathogenesis of inflammatory bowel disease and target sites for pharmacological intervention. Shown are the interactions among bacterial antigens.
Cardiovascular Risk and Psoriasis: Beyond the Traditional Risk Factors
Nat. Rev. Nephrol. doi: /nrneph
Figure 3 LncRNAs in kidney disease
Figure 5 Involvement of B cells in SLE
Figure 3 Neutrophils in liver inflammation
Figure 4 Expression of coagulation protease receptors in renal cells
Figure 1 Radiation-induced effects on tumour cells
Figure 5 Dendritic cells in liver inflammation
Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro
Figure 1 Pathological features of lupus nephritis subtypes
Figure 1 Induction of immune tolerance
Volume 79, Issue 9, Pages (May 2011)
The role of viruses in acute exacerbations of asthma
Nat. Rev. Nephrol. doi: /nrneph
Figure 1 Immune mechanisms in liver homeostasis
The Th17 immune response in renal inflammation
Figure 1 Targets for monoclonal antibodies in B-cell lineages
Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro
Nat. Rev. Nephrol. doi: /nrneph
Figure 3 Nucleic acid sensors in SLE
Nat. Rev. Nephrol. doi: /nrneph
Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro
Figure 3 TNFSF activities enhancing immune cell activation
Nat. Rev. Nephrol. doi: /nrneph
Nat. Rev. Cardiol. doi: /nrcardio
Figure 3 Molecular mechanisms of crystal-induced necroinflammation
Figure 2 Molecular pathways involved in the regulation of T-cell differentiation and cytokine production Figure 2 | Molecular pathways involved in the.
Figure 2 Prevention of antigen–antibody
Figure 1 Overview of the immunopathogenesis of ulcerative colitis
Figure 2 Roles of mTOR complexes in the kidney
Nat. Rev. Nephrol. doi: /nrneph
Figure 2 Emerging models of antibody-mediated rejection (ABMR) and
Figure 3 Differentiation and functional control of T-cell subsets
Figure 4 Macrophages in liver inflammation
Figure 3 Cascade of events leading from AKI to ALI
Nat. Rev. Nephrol. doi: /nrneph
B-Cell-Directed Therapy for Inflammatory Skin Diseases
Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro
during the alloimmune response
Figure 3 Current model of immunopathogenesis in CIDP
Figure 3 Pathological activation of complement
Figure 2 Pro-inflammatory and anti-inflammatory effects of the gut microbiota Figure 2 | Pro-inflammatory and anti-inflammatory effects of the gut microbiota.
Figure 3 Biologics that attenuate effector responses in the kidney
Autoimmunity through Cytokine-Induced Dendritic Cell Activation
Nat. Rev. Nephrol. doi: /nrneph
Figure 1 Principal pathogenic mechanisms of
Figure 2 Adaptive immunity in atherosclerosis
Role of IgE in autoimmunity
Figure 2 Biologics that target CD4+ T helper (TH)-cell subsets
Figure 1 Sequence of events in the development of autoimmune nephritis
primary Sjögren syndrome
Figure 2 Cellular contributions to the development of SLE
Figure 2 Initiators of obesity-associated inflammation in adipocytes
Simplified diagrammatic representation of a selection of mechanisms of glomerular injury. Simplified diagrammatic representation of a selection of mechanisms.
Nat. Rev. Rheumatol. doi: /nrrheum
Figure 4 Role of chemokines in dendritic cell migration
Lec.9 Cytokines.
Basophils and mast cells in renal injury
NODding off in acute kidney injury with progranulin?
Figure 1 The role of macrophages in RA
Mechanisms of virus-induced airway inflammation in chronic obstructive pulmonary disease (COPD). Mechanisms of virus-induced airway inflammation in chronic.
SLE: the many players involved in systemic autoimmunity and tissue destruction. SLE: the many players involved in systemic autoimmunity and tissue destruction.
The Biology of Intestinal Immunoglobulin A Responses
Nat. Rev. Rheumatol. doi: /nrrheum
Jacques Banchereau, Virginia Pascual  Immunity 
General overview of innate and adaptive immune responses to and regulation of black yeasts. General overview of innate and adaptive immune responses to.
Cytokines and cytokine receptors involved in type I immunity in tuberculosis. Cytokines and cytokine receptors involved in type I immunity in tuberculosis.
Figure 2 Involvement of plasmacytoid dendritic cells
Presentation transcript:

Figure 2 Cell-mediated disease mechanisms of lupus nephritis Figure 2 | Cell-mediated disease mechanisms of lupus nephritis. The sensing of immunostimulatory nucleic acids by dendritic cells drives B lymphocyte and T lymphocyte activation and the production of autoantibodies and autoantigen-specific T cells, leading to glomerular endothelium, podocyte, tubulointerstitial and vascular injury. Specific leukocyte subsets, including IL-17-producing T helper type 17 (TH17) cells, drive inflammation and contribute to renal immunopathology. B-cell- activating factor (BAFF) might increase the generation of new autoreactive B cells, inhibit B cell apoptosis and stimulate the differentiation of B cells into immunoglobulin-producing plasma cells. Infiltrating leukocytes might also provide a source of nuclear antigens and cytokines, such as interferon (IFN) α, tumour necrosis factor (TNF), IL-1 and IL-6. High mobility group box 1 (HMGB1), biglycan and histones released from immune cells can bind Toll-like receptors (TLRs) expressed by endothelial cells, leading to an inflammatory response. Inaddition, anti-double-stranded DNA (anti-dsDNA) antibodies can induce fibronectin secretion in proximal renal tubular epithelial cells, leading to TGFβ activation and collagen synthesis. Activation of the apoptosis regulator BCL-2 might also contribute to the development of tubulointerstital inflammation, whereas antiphospholipid antibody-induced thrombosis might contribute to the development of interstitial vascular inflammation. GBM, glomerular basement membrane; TCR, T-cell receptor; Treg, regulatory T cell. Yu, F. et al. (2017) Redefining lupus nephritis: clinical implications of pathophysiologic subtypes Nat. Rev. Nephrol. doi:10.1038/nrneph.2017.85